What is Fulgent Genetics, Inc.'s share buybacks?

Fulgent Genetics, Inc. (FLGT) reported share buybacks of $40.08M in Q1 2026.

How has Fulgent Genetics, Inc.'s share buybacks changed year-over-year?

Fulgent Genetics, Inc.'s share buybacks increased by 361.8% year-over-year, from $8.68M to $40.08M.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Fulgent Genetics, Inc. FLGT Share Buybacks

Share Buybacks at other companies

Labcorp HoldingsLH

$98M—

Tempus AI, Inc.TEM

$760K—

Agilent TechnologiesA

$65M-60.6%

RevvityRVTY

$86.5M-43.7%

Bio-Rad LaboratoriesBIO

$47.8M-53.1%

Opko HealthOPK

$4.77M—

Other financials

Income statement

See full

Revenue$71.1M-3.2%

Gross profit$21.5M-24.2%

Operating income-$34.6M-74.9%

Net income-$24.8M-115%

EPS (diluted)-$0.80-116%

Balance sheet

See full

Cash & equivalents$23.4M-65.2%

Total debt$8.2M+40.5%

Total equity$1.0B-6.9%

Total assets$1.2B-4.1%

Cash flow

See full

Operating cash flow$7.1M+260%

CapEx$5.2M+10.3%

Free cash flow$1.9M+121%

Valuation

See full

Market cap$552.11M-7.1%

Enterprise value$536.92M+0.7%

P/S1.7×-0.3×

Profitability

See full

Gross margin38.7%-0.1pp

Operating margin-33.1%+17.4pp

Net margin-23%+43.3pp

FCF margin-36.9%—

Returns & leverage

See full

Return on equity-6.8%+48.2pp

Debt / equity0×0.0×

Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s share buybacks?: Fulgent Genetics, Inc. (FLGT) reported share buybacks of $40.08M in Q1 2026.
How has Fulgent Genetics, Inc.'s share buybacks changed year-over-year?: Fulgent Genetics, Inc.'s share buybacks increased by 361.8% year-over-year, from $8.68M to $40.08M.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.